203 related articles for article (PubMed ID: 16116124)
1. White matter lesion severity in male and female patients with Fabry disease.
Fellgiebel A; Müller MJ; Mazanek M; Baron K; Beck M; Stoeter P
Neurology; 2005 Aug; 65(4):600-2. PubMed ID: 16116124
[TBL] [Abstract][Full Text] [Related]
2. Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression.
Dalby RB; Chakravarty MM; Ahdidan J; Sørensen L; Frandsen J; Jonsdottir KY; Tehrani E; Rosenberg R; Ostergaard L; Videbech P
Psychol Med; 2010 Aug; 40(8):1389-99. PubMed ID: 19895719
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of different MRI and MR angiography measures in Fabry disease.
Fellgiebel A; Keller I; Marin D; Müller MJ; Schermuly I; Yakushev I; Albrecht J; Bellhäuser H; Kinateder M; Beck M; Stoeter P
Neurology; 2009 Jan; 72(1):63-8. PubMed ID: 19122032
[TBL] [Abstract][Full Text] [Related]
4. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity -- a 7 T study.
Conijn MM; Hoogduin JM; van der Graaf Y; Hendrikse J; Luijten PR; Geerlings MI
Neuroimage; 2012 Jan; 59(2):950-6. PubMed ID: 21930217
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic modifiers on cerebral lesions in Fabry disease.
Altarescu G; Moore DF; Schiffmann R
Neurology; 2005 Jun; 64(12):2148-50. PubMed ID: 15985593
[TBL] [Abstract][Full Text] [Related]
6. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
[TBL] [Abstract][Full Text] [Related]
7. Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch type.
van den Boom R; Bornebroek M; Behloul F; van den Berg-Huysmans AA; Haan J; van Buchem MA
Neurology; 2005 Apr; 64(7):1288-9. PubMed ID: 15824369
[TBL] [Abstract][Full Text] [Related]
8. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
[TBL] [Abstract][Full Text] [Related]
9. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms.
Taylor WD; Macfall JR; Payne ME; McQuoid DR; Steffens DC; Provenzale JM; Krishnan KR
Psychol Med; 2007 Dec; 37(12):1763-73. PubMed ID: 17335636
[TBL] [Abstract][Full Text] [Related]
10. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
Nill M; Müller MJ; Beck M; Stoeter P; Fellgiebel A
Fortschr Neurol Psychiatr; 2006 Dec; 74(12):687-95. PubMed ID: 17167727
[TBL] [Abstract][Full Text] [Related]
12. Relationship of vascular risk to the progression of Alzheimer disease.
Borroni B; Archetti S; Ferrari M; Cesana BM; Padovani A
Neurology; 2007 Mar; 68(13):1083-4; author reply 1084. PubMed ID: 17389321
[No Abstract] [Full Text] [Related]
13. Development and clinical consequences of white matter lesions in Fabry disease: a systematic review.
Körver S; Vergouwe M; Hollak CEM; van Schaik IN; Langeveld M
Mol Genet Metab; 2018 Nov; 125(3):205-216. PubMed ID: 30213639
[TBL] [Abstract][Full Text] [Related]
14. Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults.
Kuo HK; Chen CY; Liu HM; Yen CJ; Chang KJ; Chang CC; Yu YH; Lin LY; Hwang JJ
Int J Cardiol; 2010 Aug; 143(2):184-91. PubMed ID: 19261342
[TBL] [Abstract][Full Text] [Related]
15. Gait in elderly with cerebral small vessel disease.
de Laat KF; van Norden AG; Gons RA; van Oudheusden LJ; van Uden IW; Bloem BR; Zwiers MP; de Leeuw FE
Stroke; 2010 Aug; 41(8):1652-8. PubMed ID: 20576951
[TBL] [Abstract][Full Text] [Related]
16. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
[TBL] [Abstract][Full Text] [Related]
17. APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI.
Kim M; Bae HJ; Lee J; Kang L; Lee S; Kim S; Lee JE; Lee KM; Yoon BW; Kwon O; Koo JS; Kim BK
Neurology; 2005 Nov; 65(9):1474-5. PubMed ID: 16275840
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype is related to progression of white matter lesion load.
Godin O; Tzourio C; Maillard P; Alpérovitch A; Mazoyer B; Dufouil C
Stroke; 2009 Oct; 40(10):3186-90. PubMed ID: 19644067
[TBL] [Abstract][Full Text] [Related]
19. The cerebral vasculopathy of Fabry disease.
Moore DF; Kaneski CR; Askari H; Schiffmann R
J Neurol Sci; 2007 Jun; 257(1-2):258-63. PubMed ID: 17362993
[TBL] [Abstract][Full Text] [Related]
20. Cerebral fat embolism: susceptibility-weighted magnetic resonance imaging.
Suh SI; Seol HY; Seo WK; Koh SB
Arch Neurol; 2009 Sep; 66(9):1170. PubMed ID: 19752311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
